LH · News · 20260804N

Guidance / Outlook

LABCORP HOLDINGS INC. · 2026-08-04 · Importance 57 · Surprise 60

Labcorp raised its full-year 2026 revenue and adjusted EPS guidance following Q2 results reported on August 3, 2026. Management expects continued growth and margin expansion, with particular strength in Central Laboratories and Early Development within Biopharma Laboratory Services. The reported outlook indicates that specialty testing, strategic partnerships, and operational efficiencies are expected to support performance through the remainder of 2026.

Key facts